Earnings History Data for eFFECTOR Therapeutics, Inc. (EFTR) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as STRIs. eFFECTOR Therapeutics Inc., formerly known as Locust Walk Acquisition Corp., is based in SAN DIEGO.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 09-05-2024 | PM | EFTR | eFFECTOR Therapeutics, Inc. | 8.00 | -2.16 | -2.17 | 0.00 | eFFECTOR Therapeutics GAAP EPS of -$2.16 beats by $0.01 [5/10/2024 6:33 AM] |
2.02 | -0.12 (-5.69%) |
2.01 | -0.13 (-6.07%) |
1.60 - 37.00 | 78,939 | 130,000 | 1,986 | ||
| 25-03-2024 | AH | EFTR | eFFECTOR Therapeutics, Inc. | 33.00 | -3.42 | -2.73 | 0.00 | eFFECTOR Therapeutics GAAP EPS of -$3.42, revenue of $0M [3/25/2024 6:04 PM] |
12.90 | -0.86 (-6.21%) |
12.75 | -1.01 (-7.34%) |
8.44 - 37.00 | 426,154 | 130,000 | 49,302 | ||
| 09-05-2023 | PM | EFTR | eFFECTOR Therapeutics, Inc. | 20.75 | -0.24 | -0.22 | 0.07 | eFFECTOR Therapeutics GAAP EPS of -$0.24 [5/10/2023 9:59 AM] |
0.52 | 0.0 (-0.95%) |
0.50 | -0.02 (-4.72%) |
0.34 - 2.97 | 249,707 | 200,000 | 802 | ||
| 08-03-2023 | AH | EFTR | eFFECTOR Therapeutics, Inc. | 23.00 | -0.22 | -0.18 | 0.00 | eFFECTOR Therapeutics GAAP EPS of -$0.22 beats by $0.02, revenue of $0.67M beats by $0.01M [3/8/2023 6:07 PM] |
0.50 | 0.0 (-0.42%) |
0.55 | 0.05 (9.54%) |
0.35 - 5.25 | 218,445 | 110,000 | 1,345 | ||
| 07-11-2022 | AH | EFTR | eFFECTOR Therapeutics, Inc. | 22.00 | -0.23 | -0.27 | 0.00 | eFFECTOR Therapeutics GAAP EPS of -$0.23, revenue of $0.87M [11/7/2022 5:06 PM] |
0.4896 | 0.0 (-0.10%) |
0.53 | 0.04 (7.22%) |
0.47 - 11.95 | 58,296 | 180,000 | 101 | ||
| 10-05-2022 | AH | EFTR | eFFECTOR Therapeutics, Inc. | 112.00 | 0.07 | -0.32 | 0.00 | eFFECTOR Therapeutics GAAP EPS of $0.08 [5/10/2022 5:50 PM] |
2.13 | -0.27 (-11.25%) |
0.0 | 0.0 (0.00%) |
2.03 - 40.42 | 23,698 | 20,000 | 0 | ||
| 16-03-2022 | AH | EFTR | eFFECTOR Therapeutics, Inc. | 155.00 | 0.44 | -0.25 | 0.00 | eFFECTOR Therapeutics GAAP EPS of $0.44, revenue of $0.31M [3/16/2022 5:15 PM] |
4.14 | 0.07 (1.72%) |
0.0 | 0.0 (0.00%) |
3.50 - 40.42 | 55,819 | 60,338 | 0 | ||